Compared with baseline LDL-C levels, all patients in both groups showed a trend toward decreased LDL-C levels after 2 weeks of treatment ( Supplementary Figure 1 ).
← all excerpts
Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
1
—
—